A new article featuring #GARFIELDAF data on almost 5,000 patients in Japan (9% of the global study) is out in @CircAHA. See how #AFib risk profiles, treatment patterns and 1-year outcomes differ to the rest of the world. Read the full paper here: https://t.co/MMHR4K551q #RWE https://t.co/QWEJKaImoE